Rgenta Therapeutics
Latest round
- Series A
Last raised
- May 2023
Total raised
- $98M
Investors
- 10
About Rgenta Therapeutics
Rgenta Therapeutics, Inc.Founded in 2018, Rgenta Therapeutics, Inc. is headquartered in Woburn, US. The company specializes in the development of RNA-targeting therapies. The founders include Simon Xi, Travis Wager, and Zhiping Weng, with Simon Xi serving as the CEO.00 mn from HighLight Capital.Rgenta Therapeutics focuses on innovative RNA-targeting small molecule therapies aimed at treating complex diseases, particularly in oncology and central nervous system disorders. Their offerings include small molecules that modulate RNA interactions to regulate splicing and gene expression. These therapies are designed to address high-impact areas such as solid tumors and genetic disorders, with initial applications including Huntington’s disease.Rgenta Therapeutics generates revenue through collaborations with stakeholders in healthcare and pharmaceuticals, including biotechnology firms and academic institutions. They engage clients through licensing agreements to access their proprietary RNA-targeting technology and products. The company plans to continue developing RNA-targeting therapies and aims to expand its market presence in North America and Europe, with specific initiatives targeting areas of high unmet medical need. New products are in the design stage, and Rgenta is focused on advancing their therapeutic applications to launch in the coming years.
Who invested in Rgenta Therapeutics
10 investors across 4 rounds
See all investors in Rgenta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rgenta Therapeutics
Who invested in Rgenta Therapeutics?
Rgenta Therapeutics has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rgenta Therapeutics raised?
Rgenta Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Rgenta Therapeutics last raise money?
Rgenta Therapeutics's most recent round on record is a Series A, in May 2023.
What does Rgenta Therapeutics do?
Rgenta Therapeutics is a pharmaceuticals company.
Where is Rgenta Therapeutics headquartered?
Rgenta Therapeutics is headquartered in Woburn, US.
Which VCs invest in companies like Rgenta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Rgenta Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Rgenta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.